US Patent Issued to Stilla Technologies on Sept. 15 for "Determination of nucleic acid sequence concentrations" (French Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,735,739, issued on Sept. 15, was assigned to Stilla Technologies (Villejuif, France).

"Determination of nucleic acid sequence concentrations" was invented by Barbara Andre (Paris) and Remi Dangla (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of determining the concentration of a detected sequence in non-fragmented nucleic acids by applying a correction coefficient to the concentration of said detected sequence measured in fragmented nucleic acids."

The patent was filed on Oct. 16, 2020, under Application No. 17/768,820.

*For further information, including images, charts and tables, please visit: http:...